259 related articles for article (PubMed ID: 22886266)
1. Characterization of single-domain antibodies with an engineered disulfide bond.
Hussack G; Mackenzie CR; Tanha J
Methods Mol Biol; 2012; 911():417-29. PubMed ID: 22886266
[TBL] [Abstract][Full Text] [Related]
2. Improvement of single domain antibody stability by disulfide bond introduction.
Hagihara Y; Saerens D
Methods Mol Biol; 2012; 911():399-416. PubMed ID: 22886265
[TBL] [Abstract][Full Text] [Related]
3. Solubility and stability engineering of human VH domains.
Kim DY; Ding W; Tanha J
Methods Mol Biol; 2012; 911():355-72. PubMed ID: 22886262
[TBL] [Abstract][Full Text] [Related]
4. Enhanced production of a single domain antibody with an engineered stabilizing extra disulfide bond.
Liu JL; Goldman ER; Zabetakis D; Walper SA; Turner KB; Shriver-Lake LC; Anderson GP
Microb Cell Fact; 2015 Oct; 14():158. PubMed ID: 26449768
[TBL] [Abstract][Full Text] [Related]
5. The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies.
Akazawa-Ogawa Y; Uegaki K; Hagihara Y
J Biochem; 2016 Jan; 159(1):111-21. PubMed ID: 26289739
[TBL] [Abstract][Full Text] [Related]
6. Improvement of proteolytic stability through in silico engineering.
Rutten L; de Haard H; Verrips T
Methods Mol Biol; 2012; 911():373-81. PubMed ID: 22886263
[TBL] [Abstract][Full Text] [Related]
7. Protease-resistant single-domain antibodies inhibit Campylobacter jejuni motility.
Hussack G; Riazi A; Ryan S; van Faassen H; MacKenzie R; Tanha J; Arbabi-Ghahroudi M
Protein Eng Des Sel; 2014 Jun; 27(6):191-8. PubMed ID: 24742504
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
[TBL] [Abstract][Full Text] [Related]
9. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of disulfide bond position to enhance the thermal stability of a highly stable single domain antibody.
Zabetakis D; Olson MA; Anderson GP; Legler PM; Goldman ER
PLoS One; 2014; 9(12):e115405. PubMed ID: 25526640
[TBL] [Abstract][Full Text] [Related]
11. Engineered single-domain antibodies with high protease resistance and thermal stability.
Hussack G; Hirama T; Ding W; Mackenzie R; Tanha J
PLoS One; 2011; 6(11):e28218. PubMed ID: 22140551
[TBL] [Abstract][Full Text] [Related]
12. Selection of human VH single domains with improved biophysical properties by phage display.
Dudgeon K; Rouet R; Famm K; Christ D
Methods Mol Biol; 2012; 911():383-97. PubMed ID: 22886264
[TBL] [Abstract][Full Text] [Related]
13. Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein.
Liu JL; Shriver-Lake LC; Anderson GP; Zabetakis D; Goldman ER
Microb Cell Fact; 2017 Dec; 16(1):223. PubMed ID: 29233140
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
[TBL] [Abstract][Full Text] [Related]
15. Disulfide linkage engineering for improving biophysical properties of human VH domains.
Kim DY; Kandalaft H; Ding W; Ryan S; van Faassen H; Hirama T; Foote SJ; MacKenzie R; Tanha J
Protein Eng Des Sel; 2012 Oct; 25(10):581-9. PubMed ID: 22942392
[TBL] [Abstract][Full Text] [Related]
16. Single domain antibodies with VH hallmarks are positively selected during panning of llama (Lama glama) naïve libraries.
Monegal A; Olichon A; Bery N; Filleron T; Favre G; de Marco A
Dev Comp Immunol; 2012 Jan; 36(1):150-6. PubMed ID: 21767565
[TBL] [Abstract][Full Text] [Related]
17. Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy.
Harmsen MM; van Solt CB; van Zijderveld-van Bemmel AM; Niewold TA; van Zijderveld FG
Appl Microbiol Biotechnol; 2006 Sep; 72(3):544-51. PubMed ID: 16450109
[TBL] [Abstract][Full Text] [Related]
18. Negative tail fusions can improve ruggedness of single domain antibodies.
Goldman ER; Brozozog-Lee PA; Zabetakis D; Turner KB; Walper SA; Liu JL; Anderson GP
Protein Expr Purif; 2014 Mar; 95():226-32. PubMed ID: 24440507
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical improvement of rabbit derived single-domain antibodies by substitutions with amino acids conserved in camelid antibodies.
Shinozaki N; Hashimoto R; Noda M; Uchiyama S
J Biosci Bioeng; 2018 Jun; 125(6):654-661. PubMed ID: 29398547
[TBL] [Abstract][Full Text] [Related]
20. Llama single domain antibodies as a tool for molecular mimicry.
Zarebski LM; Urrutia M; Goldbaum FA
J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
